|
Volumn 67, Issue 14, 2000, Pages 1667-1682
|
Is there a basis for novel pharmacotherapy of autism?
|
Author keywords
Autism; PDD (pervasive developmental disorder); Psychotherapeutics; Secretin
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ASCORBIC ACID;
BUSPIRONE;
CARBAMAZEPINE;
CLONIDINE;
CLOZAPINE;
DEXAMPHETAMINE;
DIMETHYLGLYCINE;
FENFLURAMINE;
FLUOXETINE;
FLUPHENAZINE;
FLUVOXAMINE;
FOLIC ACID;
HALOPERIDOL;
IMMUNOGLOBULIN;
METHYLPHENIDATE;
NALTREXONE;
NEUROLEPTIC AGENT;
OLANZAPINE;
OPIATE ANTAGONIST;
PEMOLINE;
PIMOZIDE;
PROPRANOLOL;
PYRIDOXINE;
RISPERIDONE;
SECRETIN;
SEROTONIN RECEPTOR AFFECTING AGENT;
SEROTONIN UPTAKE INHIBITOR;
UNINDEXED DRUG;
VALPROIC ACID;
AUTISM;
BODY WEIGHT DISORDER;
CLINICAL TRIAL;
DIET SUPPLEMENTATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
IATROGENIC DISEASE;
NEUROCHEMISTRY;
NEUROPATHOLOGY;
NONHUMAN;
PSYCHOPHARMACOTHERAPY;
SEDATION;
SHORT SURVEY;
SIDE EFFECT;
VITAMIN SUPPLEMENTATION;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIPSYCHOTIC AGENTS;
AUTISTIC DISORDER;
BUSPIRONE;
DIETARY SUPPLEMENTS;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
MOLECULAR SEQUENCE DATA;
NALTREXONE;
NARCOTIC ANTAGONISTS;
RISPERIDONE;
SECRETIN;
SEROTONIN AGONISTS;
SEROTONIN UPTAKE INHIBITORS;
|
EID: 0034714506
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(00)00763-3 Document Type: Review |
Times cited : (26)
|
References (107)
|